These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35071438)

  • 1. Mitosis-related gene
    Shao C; Wang Y; Duan H; Ding P; Zhang Y; Ning J; Han J; Jiang T; Yan X
    Ann Transl Med; 2021 Dec; 9(23):1744. PubMed ID: 35071438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DNA damage repair-related gene
    Shao C; Wang Y; Pan M; Guo K; Molnar TF; Kocher F; Seeber A; Barr MP; Navarro A; Han J; Ma Z; Yan X
    Transl Lung Cancer Res; 2021 Dec; 10(12):4600-4616. PubMed ID: 35070764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types.
    Wu Y; Huang W; Xie Y; Wang C; Luo N; Chen Y; Wang L; Cheng Z; Gao Z; Liu S
    Front Mol Biosci; 2022; 9():743515. PubMed ID: 35372497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of
    Feng Y; Wang Y; Guo K; Feng J; Shao C; Pan M; Ding P; Liu H; Duan H; Lu D; Wang Z; Zhang Y; Zhang Y; Han J; Li X; Yan X
    Ann Transl Med; 2022 Apr; 10(8):466. PubMed ID: 35571400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mitosis-related gene
    Pan M; Wang Y; Wang Z; Duan H; Shao C; Ding P; Lei J; Zhao J; Ma Z; Zhang F; Han J; Yan X
    Ann Transl Med; 2023 Jan; 11(2):117. PubMed ID: 36819584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
    Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
    Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-Cancer Analysis Revealed
    Liu J; Wang Y; Yin J; Yang Y; Geng R; Zhong Z; Ni S; Liu W; Du M; Yu H; Bai J
    J Oncol; 2022; 2022():3477148. PubMed ID: 35069733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggresome-Autophagy Associated Gene HDAC6 Is a Potential Biomarker in Pan-Cancer, Especially in Colon Adenocarcinoma.
    Zhang Z; Zhang X; Huang A
    Front Oncol; 2021; 11():718589. PubMed ID: 34485153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. System Analysis of Adaptor-Related Protein Complex 1 Subunit Mu 2 (AP1M2) on Malignant Tumors: A Pan-Cancer Analysis.
    Yi Y; Zhang Q; Shen Y; Gao Y; Fan X; Chen S; Ye X; Xu J
    J Oncol; 2022; 2022():7945077. PubMed ID: 35154321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Pan-Cancer Analysis and the Regulatory Mechanism of ASF1B, a Gene Associated With Thyroid Cancer Prognosis in the Tumor Micro-Environment.
    Ma J; Han W; Lu K
    Front Oncol; 2021; 11():711756. PubMed ID: 34490109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of centromere protein N as novel biomarkers for gastric adenocarcinoma.
    Wang X; Zhang K; Fu C; Wu F; Zhang J; Han B; Pan H; Luan L
    Cancer Rep (Hoboken); 2023 Apr; 6(4):e1798. PubMed ID: 36916294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-Cancer Analysis Based on
    Zhang Y; Wang S; Han S; Feng Y
    Front Oncol; 2022; 12():844794. PubMed ID: 35359375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise-induced IL-15 acted as a positive prognostic implication and tumor-suppressed role in pan-cancer.
    Luo Z; He Z; Qin H; Chen Y; Qi B; Lin J; Sun Y; Sun J; Su X; Long Z; Chen S
    Front Pharmacol; 2022; 13():1053137. PubMed ID: 36467072
    [No Abstract]   [Full Text] [Related]  

  • 16. Pan-Cancer Analysis of the N6-Methyladenosine Eraser FTO as a Potential Prognostic and Immunological Biomarker.
    Zhao C; Liu Y; Ju S; Wang X
    Int J Gen Med; 2021; 14():7411-7422. PubMed ID: 34744452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression.
    Zhang Z; Li L; Li M; Wang X
    Comput Struct Biotechnol J; 2020; 18():2438-2444. PubMed ID: 32905022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer.
    Chen G; Luo D; Zhong N; Li D; Zheng J; Liao H; Li Z; Lin X; Chen Q; Zhang C; Lu Y; Chan YT; Ren Q; Wang N; Feng Y
    Front Immunol; 2022; 13():857308. PubMed ID: 35345673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-Cancer Analysis Reveals PPRC1 as a Novel Prognostic Biomarker in Ovarian Cancer and Hepatocellular Carcinoma.
    Ruan X; Cui G; Li C; Sun Z
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.